Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation - Wikidata - thesis-toulmin - TriplyDB

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

http://www.wikidata.org/entity/Q22306317

about

sameAs

Pulmonary hypertension survival effects and treatment options in cystic fibrosis Lung transplantation for cystic fibrosis The utility of preoperative six-minute-walk distance in lung transplantation Update in cystic fibrosis 2012.Elevated CO2 selectively inhibits interleukin-6 and tumor necrosis factor expression and decreases phagocytosis in the macrophage.Elevated CO(2) levels cause mitochondrial dysfunction and impair cell proliferation.High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1).Hypercapnia Inhibits Autophagy and Bacterial Killing in Human Macrophages by Increasing Expression of Bcl-2 and Bcl-xL.Pulmonary acceleration time to optimize the timing of lung transplant in cystic fibrosis.Hypercapnia: a nonpermissive environment for the lung.Analysis of Cystic Fibrosis in Federation of Bosnia and Herzegovina.Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.Outcomes of Chinese Patients with End-stage Pulmonary Disease while Awaiting Lung Transplantation: A Single-center Study.Update in transplantation 2006.Update in cystic fibrosis 2006 Advancing outcome measures for the new era of drug development in cystic fibrosis.Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City.Protein kinase A-Iα regulates Na,K-ATPase endocytosis in alveolar epithelial cells exposed to high CO(2) concentrations.Update in transplantation 2007.Association between pulmonary function and sputum biomarkers in cystic fibrosis.Elevated CO2 suppresses specific Drosophila innate immune responses and resistance to bacterial infection Hypercapnia impairs lung neutrophil function and increases mortality in murine pseudomonas pneumonia.Carbon dioxide-sensing in organisms and its implications for human disease.Polysomnographic differences associated with pulmonary hypertension in patients with advanced lung disease due to cystic fibrosis.Focused Screening Identifies Evoxine as a Small Molecule That Counteracts CO2-Induced Immune Suppression.Lung transplantation for cystic fibrosis: an update.Effects of hypercapnia on the lung.Identification of Drosophila Zfh2 as a Mediator of Hypercapnic Immune Regulation by a Genome-Wide RNA Interference Screen.Halting the spread of epidemic pseudomonas aeruginosa in an adult cystic fibrosis centre: a prospective cohort study.A global perspective of lung transplantation: Part 1 - Recipient selection and choice of procedure.Increased Mortality in Adult Cystic Fibrosis Patients with Medicaid Insurance Awaiting Lung Transplantation.Prognostic significance of pulmonary hypertension in patients with cystic fibrosis: A systematic review and meta-analysis.Life-space mobility is associated with frequency of hospitalization in adults with cystic fibrosis.Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation.Mortality rate of patients with cystic fibrosis on the waiting list and within one year after lung transplantation: a survey of Italian CF centers.Lung Transplantation in Idiopathic Pulmonary Fibrosis Hypercapnia Alters Expression of Immune Response, Nucleosome Assembly and Lipid Metabolism Genes in Differentiated Human Bronchial Epithelial Cells

P2860

Q26825432-4720EB4A-47FC-4319-80E7-D5D5E4E152BB Q28749501-E96579D0-1191-49B8-80F1-F59D7005A3B4 Q33735636-26E23F1B-E04C-4AC9-A96A-4E9BDBED455F Q33738510-844119EB-369E-4642-A7BC-6B02FC3033A0 Q33919428-1DB6D493-86F9-4FF7-8CF7-5DAB99DAABD4 Q35423256-4FB4E20B-3DC6-4441-AB97-E697DA657FC5 Q35580888-DA428B7F-01BE-4C7A-BDBB-696D492D9B82 Q35613035-CD80FFA6-0491-4E1B-B07F-CFDE55388B20 Q35929774-6CB60447-3EF4-403F-B396-D073FE46DA7E Q35987294-847A007F-68EF-4073-886C-3AD2CFEA49C2 Q36176446-EB0FA1E4-A426-4074-84E3-A74991860DF5 Q36658777-2CF5051A-FF6F-440F-BE2E-96EDEEF73F18 Q36701699-3DD6C496-FE24-4353-AEAE-37CC4FC6B2AE Q36737002-28D70255-30DA-4578-8F7F-C33A19955A6B Q36779226-271F963B-302E-49C1-84A5-BC0F9659AC3F Q36891530-D0692349-2B08-4C34-B8FA-DE39030E3822 Q36944698-002E6FCF-F00D-4612-A6B5-8ACB2B52BFEF Q36999821-620D91D2-9F1A-4E77-8615-79CFAE115488 Q37156062-283C7B37-B6DC-44DB-8F5D-9B1638778097 Q37287157-66A6B55A-ADC2-45E6-A3B2-ADE4534DA5D4 Q37413464-5590A1F2-9E06-4C10-97E6-6774AC5226E5 Q37596440-3E04FFCC-C9F3-4BC9-B49D-59EAA5F16008 Q37623230-B4BD3C37-FB55-484E-978F-9D83AABF44E2 Q38199621-D0C4BA34-57C8-4300-8523-4EB77D9840A8 Q38809312-B12F1B16-E340-42C6-B659-FC7A0220CD05 Q39008114-0354042F-D1DF-4FDB-8BDB-A0D2593FCE2B Q39065369-3247A4A8-313D-40A9-B353-2E4FA21BF3AE Q40880372-11D0EA06-57BE-4F6A-B34C-C3F324901334 Q42274835-431D4F80-65AC-4F89-9E1B-161DA689C6C0 Q42378561-4E663D83-DE44-41F3-B12D-4EF914E45153 Q48119127-EDCCB068-A4B5-4B2E-974F-DD19E50378BD Q50003442-48A54BC7-5C40-40F2-86C4-3CE96E9F36F9 Q53029501-12BBB963-5C86-4109-9D33-01C5993BCD93 Q53171875-36EC9D14-90C5-4442-8178-78DA7D0D07DC Q55454090-6AC6105D-B61F-47BA-8042-227427304626 Q58710324-908BF552-CE42-48A8-B4BB-625B5B2B49C6 Q58756398-8315972E-93C2-4864-9B33-5665BA8ADF9E

P2860

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

http://www.wikidata.org/entity/Q22306317

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

@ast

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

@en

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

@en-gb

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

@nl

type

label

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

@ast

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

@en

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

@en-gb

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

@nl

altLabel

Risk factors for death of patients with cystic fibrosis awaiting lung transplantation

@en

prefLabel

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

@ast

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

@en

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

@en-gb

Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation

@nl

P1433

Q22306317-CB7A1BE3-0E8E-44C5-9747-B66C81FB42C6

P1476

Q22306317-A9741711-E734-4050-948A-53208571E25C

P2093

Q22306317-01C0E748-D4A4-4EE5-BB14-28D84B641D07

Q22306317-17E45C4E-1C8B-4D09-ABE8-62A8E7E48BAE

Q22306317-1BCC7BC7-EEBC-4838-8507-B3B340BC70BB

Q22306317-49E31FEF-1310-4A9D-99B9-1D2EC3CDFB6A

Q22306317-95832B84-2050-4D09-A838-3284F1560989

Q22306317-BEF51767-A58E-4B12-993D-11E6C0A860CE

Q22306317-E824FF0A-B792-4370-9C2B-6F3B196CAA4E

P2860

Q22306317-0474481A-34C3-4E08-BCAD-240C17AFA9FE

Q22306317-0EB1C303-FD22-4A2C-B613-18D98ECD19D8

Q22306317-1300B565-1983-4BE7-9491-F8D3D44DB515

Q22306317-1A42D2DA-CCA5-41D1-AC5C-FBE9C1EF8B01

Q22306317-1CB99D62-59EA-4E46-9669-7F9D8EF96273

Q22306317-302DE8C0-6F73-49FB-B6A4-7EF06EFA6D12

Q22306317-35C3958E-261F-4A67-9A4F-59D9C16A4F0B

Q22306317-431862DF-DDFE-4974-BF9E-3D4351B6C576

Q22306317-442E2DD1-67FF-4F07-87EC-F08DE2EE49B7

Q22306317-485AD72B-95D2-4FDC-B96F-7EFC23F8B273

P304

Q22306317-83775258-93CE-424D-930C-B53B16B8F983

P31

Q22306317-12A813BF-6975-43B7-9117-18CCC5E02A43

P356

Q22306317-82168983-B862-4A18-B01C-6FB7BEB0B40F

P407

Q22306317-0E7AEC78-89C8-44E9-B866-5BE2B23C39DF

P433

Q22306317-E4FE1F99-B6AA-4ED1-B591-383D4CB24BA8

P478

Q22306317-7C852066-49F6-40C2-9F80-F0CE5C3770F6

P50

Q22306317-4266C072-E130-4C22-B8E0-D10009FE4452

Q22306317-55A4D7FC-8F0D-47C9-AC9C-6D1AAAD3DBC4

Q22306317-D3848973-9DB6-405A-BFD1-FFDAB7833A63

P577

Q22306317-1A906E5D-0E17-414B-890B-CA22AF397F7D

P5875

Q22306317-5D53584E-BA37-4774-8B49-9F87229A519B

P698

Q22306317-3ABD7AC0-E936-487B-B14E-0CB78417E8CB

P921

Q22306317-6CAAD387-4879-4495-8156-776CFE5574C5

Q22306317-C094AB35-A169-4C81-9136-9BC7FB6F3AE5

Q22306317-E518AFD4-1A4A-4ACC-998C-EB0EDD488C13

P932

Q22306317-E2AF5725-4181-4780-8BAB-E8FE76F3CFD8

P356

RCCM.200410-1369OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Risk factors for death of patients with cystic fibrosis awaiting lung transplantation

@en

P2093

Cecilia Chaparro

http://www.w3.org/2001/XMLSchema#string

Greta R Bunin

http://www.w3.org/2001/XMLSchema#string

Justin Y Yee

http://www.w3.org/2001/XMLSchema#string

Noreen R Henig

http://www.w3.org/2001/XMLSchema#string

Richard A Belkin

http://www.w3.org/2001/XMLSchema#string

Robert M Kotloff

http://www.w3.org/2001/XMLSchema#string

Sharon X Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Predictive 5-year survivorship model of cystic fibrosis.

Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1 may adversely affect overall survival.

Lung transplantation.

Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection.

Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease.

ATS statement: guidelines for the six-minute walk test.

Gender gap in cystic fibrosis mortality.

Wasting as an independent predictor of mortality in patients with cystic fibrosis.

Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.

A prognostic model for the prediction of survival in cystic fibrosis.

P304

659-666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200410-1369OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

173

http://www.w3.org/2001/XMLSchema#string

P50

Ronald C. Rubenstein

David A. Lipson

Lianne G Singer

P577

2005-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7383163

http://www.w3.org/2001/XMLSchema#string

P698

16387803

http://www.w3.org/2001/XMLSchema#string

P921

lung transplant

cystic fibrosis

P932

2662949

http://www.w3.org/2001/XMLSchema#string